Wang Angela Yee-Moon, Elsurer Afsar Rengin, Sussman-Dabach Elizabeth J, White Jennifer A, MacLaughlin Helen, Ikizler T Alp
Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, People's Republic of China.
Department of Nephrology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey; Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee.
Am J Kidney Dis. 2024 Mar;83(3):370-385. doi: 10.1053/j.ajkd.2023.09.005. Epub 2023 Oct 24.
All vitamins play essential roles in various aspects of body function and systems. Patients with chronic kidney disease (CKD), including those receiving dialysis, may be at increased risk of developing vitamin deficiencies due to anorexia, poor dietary intake, protein energy wasting, restricted diet, dialysis loss, or inadequate sun exposure for vitamin D. However, clinical manifestations of most vitamin deficiencies are usually subtle or undetected in this population. Testing for circulating levels is not undertaken for most vitamins except folate, B, and 25-hydroxyvitamin D because assays may not be available or may be costly to perform and do not always correlate with body stores. The last systematic review through 2016 was performed for the Kidney Disease Outcome Quality Initiative (KDOQI) 2020 Nutrition Guideline update, so this article summarizes the more recent evidence. We review the use of vitamins supplementation in the CKD population. To date there have been no randomized trials to support the benefits of any vitamin supplementation for kidney, cardiovascular, or patient-centered outcomes. The decision to supplement water-soluble vitamins should be individualized, taking account the patient's dietary intake, nutritional status, risk of vitamins deficiency/insufficiency, CKD stage, comorbid status, and dialysis loss. Nutritional vitamin D deficiency should be corrected, but the supplementation dose and formulation need to be personalized, taking into consideration the degree of 25-hydroxyvitamin D deficiency, parathyroid hormone levels, CKD stage, and local formulation. Routine supplementation of vitamins A and E is not supported due to potential toxicity. Although more trial data are required to elucidate the roles of vitamin supplementation, all patients with CKD should undergo periodic assessment of dietary intake and aim to receive various vitamins through natural food sources and a healthy eating pattern that includes vitamin-dense foods.
所有维生素在身体功能和系统的各个方面都发挥着重要作用。慢性肾脏病(CKD)患者,包括接受透析的患者,由于厌食、饮食摄入不足、蛋白质能量消耗、饮食受限、透析丢失或维生素D日照不足等原因,可能有更高的维生素缺乏风险。然而,在这一人群中,大多数维生素缺乏的临床表现通常很轻微或未被发现。除了叶酸、维生素B和25-羟基维生素D外,大多数维生素不进行循环水平检测,因为可能没有检测方法,或者检测成本高昂,而且检测结果并不总是与体内储备相关。截至2016年的最后一项系统评价是为《肾脏病改善全球预后(KDIGO)2020营养指南》更新而进行的,因此本文总结了更新的证据。我们回顾了CKD人群中维生素补充剂的使用情况。迄今为止,尚无随机试验支持补充任何维生素对肾脏、心血管或以患者为中心的结局有益。水溶性维生素的补充决策应个体化,考虑患者的饮食摄入、营养状况、维生素缺乏/不足风险、CKD分期、合并症状况和透析丢失情况。营养性维生素D缺乏应予以纠正,但补充剂量和制剂需要个体化,要考虑25-羟基维生素D缺乏程度、甲状旁腺激素水平、CKD分期和当地制剂情况。由于潜在毒性,不支持常规补充维生素A和E。尽管需要更多试验数据来阐明维生素补充的作用,但所有CKD患者都应定期评估饮食摄入,并通过天然食物来源以及包括富含维生素食物的健康饮食模式来摄入各种维生素。